作者: Ge Jin , Li-Hua Wang , Xue-Fei Ji , Tian-Yan Chi , Yue Qi
DOI: 10.1016/J.NEULET.2014.04.032
关键词: Beta (finance) 、 Endocrinology 、 Internal medicine 、 Blot 、 Amyloid precursor protein 、 Xanthoceraside 、 Neuroscience 、 Hippocampus 、 Amyloid deposition 、 Genetically modified mouse 、 Phosphorylation 、 Chemistry
摘要: Xanthoceraside, a triterpenoid saponin, has been shown to reverse cognitive deficits in several Alzheimer's disease (AD) animal models. However, the effects of xanthoceraside on Aβ deposition pathology and APP processing AD are unclear. Here, we show that at doses 0.08 0.32 mg/kg/d for 6 months significantly improved learning memory impairment transgenic mice assessed by Y maze novel object recognition tests. Immunohistochemical analyses revealed strongly attenuated β-amyloid brains mice. Western blotting decreased tau phosphorylation protein levels Ser396 Ser404 hippocampus; also GSK-3β phosphorylation. These results suggest could be promising candidate therapy AD.